4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001931356-26-000006
Options or other derivatives
- CEO and President acquired 269,621 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Angel Matthew CEO and President | 2026-02-04 | Grant or award · Employee Stock Option (right to buy) | +269,621 | 269,621 | D | ||
Loading xslF345X05/form4-02062026_090210.xml…